Cargando…

Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research

Brain imaging research studies increasingly use “de-facing” software to remove or replace facial imagery before public data sharing. Several works have studied the effects of de-facing software on brain imaging biomarkers by directly comparing automated measurements from unmodified vs de-faced image...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Christopher G., Kremers, Walter K., Weigand, Stephen D., Prakaashana, Carl M., Senjem, Matthew L., Przybelski, Scott A., Lowe, Val J., Gunter, Jeffrey L., Kantarci, Kejal, Vemuri, Prashanthi, Graff-Radford, Jonathan, Petersen, Ronald C., Knopman, David S., Jack Jr., Clifford R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502400/
https://www.ncbi.nlm.nih.gov/pubmed/37703605
http://dx.doi.org/10.1016/j.nicl.2023.103507
_version_ 1785106315527323648
author Schwarz, Christopher G.
Kremers, Walter K.
Weigand, Stephen D.
Prakaashana, Carl M.
Senjem, Matthew L.
Przybelski, Scott A.
Lowe, Val J.
Gunter, Jeffrey L.
Kantarci, Kejal
Vemuri, Prashanthi
Graff-Radford, Jonathan
Petersen, Ronald C.
Knopman, David S.
Jack Jr., Clifford R.
author_facet Schwarz, Christopher G.
Kremers, Walter K.
Weigand, Stephen D.
Prakaashana, Carl M.
Senjem, Matthew L.
Przybelski, Scott A.
Lowe, Val J.
Gunter, Jeffrey L.
Kantarci, Kejal
Vemuri, Prashanthi
Graff-Radford, Jonathan
Petersen, Ronald C.
Knopman, David S.
Jack Jr., Clifford R.
author_sort Schwarz, Christopher G.
collection PubMed
description Brain imaging research studies increasingly use “de-facing” software to remove or replace facial imagery before public data sharing. Several works have studied the effects of de-facing software on brain imaging biomarkers by directly comparing automated measurements from unmodified vs de-faced images, but most research brain images are used in analyses of correlations with cognitive measurements or clinical statuses, and the effects of de-facing on these types of imaging-to-cognition correlations has not been measured. In this work, we focused on brain imaging measures of amyloid (A), tau (T), neurodegeneration (N), and vascular (V) measures used in Alzheimer’s Disease (AD) research. We created a retrospective sample of participants from three age- and sex-matched clinical groups (cognitively unimpaired, mild cognitive impairment, and AD dementia, and we performed region- and voxel-wise analyses of: hippocampal volume (N), white matter hyperintensity volume (V), amyloid PET (A), and tau PET (T) measures, each from multiple software pipelines, on their ability to separate cognitively defined groups and their degrees of correlation with age and Clinical Dementia Rating (CDR)–Sum of Boxes (CDR-SB). We performed each of these analyses twice: once with unmodified images and once with images de-faced with leading de-facing software mri_reface, and we directly compared the findings and their statistical strengths between the original vs. the de-faced images. Analyses with original and with de-faced images had very high agreement. There were no significant differences between any voxel-wise comparisons. Among region-wise comparisons, only three out of 55 correlations were significantly different between original and de-faced images, and these were not significant after correction for multiple comparisons. Overall, the statistical power of the imaging data for AD biomarkers was almost identical between unmodified and de-faced images, and their analyses results were extremely consistent.
format Online
Article
Text
id pubmed-10502400
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105024002023-09-16 Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research Schwarz, Christopher G. Kremers, Walter K. Weigand, Stephen D. Prakaashana, Carl M. Senjem, Matthew L. Przybelski, Scott A. Lowe, Val J. Gunter, Jeffrey L. Kantarci, Kejal Vemuri, Prashanthi Graff-Radford, Jonathan Petersen, Ronald C. Knopman, David S. Jack Jr., Clifford R. Neuroimage Clin Regular Article Brain imaging research studies increasingly use “de-facing” software to remove or replace facial imagery before public data sharing. Several works have studied the effects of de-facing software on brain imaging biomarkers by directly comparing automated measurements from unmodified vs de-faced images, but most research brain images are used in analyses of correlations with cognitive measurements or clinical statuses, and the effects of de-facing on these types of imaging-to-cognition correlations has not been measured. In this work, we focused on brain imaging measures of amyloid (A), tau (T), neurodegeneration (N), and vascular (V) measures used in Alzheimer’s Disease (AD) research. We created a retrospective sample of participants from three age- and sex-matched clinical groups (cognitively unimpaired, mild cognitive impairment, and AD dementia, and we performed region- and voxel-wise analyses of: hippocampal volume (N), white matter hyperintensity volume (V), amyloid PET (A), and tau PET (T) measures, each from multiple software pipelines, on their ability to separate cognitively defined groups and their degrees of correlation with age and Clinical Dementia Rating (CDR)–Sum of Boxes (CDR-SB). We performed each of these analyses twice: once with unmodified images and once with images de-faced with leading de-facing software mri_reface, and we directly compared the findings and their statistical strengths between the original vs. the de-faced images. Analyses with original and with de-faced images had very high agreement. There were no significant differences between any voxel-wise comparisons. Among region-wise comparisons, only three out of 55 correlations were significantly different between original and de-faced images, and these were not significant after correction for multiple comparisons. Overall, the statistical power of the imaging data for AD biomarkers was almost identical between unmodified and de-faced images, and their analyses results were extremely consistent. Elsevier 2023-09-09 /pmc/articles/PMC10502400/ /pubmed/37703605 http://dx.doi.org/10.1016/j.nicl.2023.103507 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Schwarz, Christopher G.
Kremers, Walter K.
Weigand, Stephen D.
Prakaashana, Carl M.
Senjem, Matthew L.
Przybelski, Scott A.
Lowe, Val J.
Gunter, Jeffrey L.
Kantarci, Kejal
Vemuri, Prashanthi
Graff-Radford, Jonathan
Petersen, Ronald C.
Knopman, David S.
Jack Jr., Clifford R.
Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
title Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
title_full Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
title_fullStr Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
title_full_unstemmed Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
title_short Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
title_sort effects of de-facing software mri_reface on utility of imaging biomarkers used in alzheimer’s disease research
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502400/
https://www.ncbi.nlm.nih.gov/pubmed/37703605
http://dx.doi.org/10.1016/j.nicl.2023.103507
work_keys_str_mv AT schwarzchristopherg effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT kremerswalterk effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT weigandstephend effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT prakaashanacarlm effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT senjemmatthewl effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT przybelskiscotta effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT lowevalj effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT gunterjeffreyl effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT kantarcikejal effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT vemuriprashanthi effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT graffradfordjonathan effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT petersenronaldc effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT knopmandavids effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch
AT jackjrcliffordr effectsofdefacingsoftwaremrirefaceonutilityofimagingbiomarkersusedinalzheimersdiseaseresearch